论文部分内容阅读
支气管动脉是抗癌药物进入肺部肿瘤的最佳途径。我院自1989年2月至1994年12月对83例中晚期肺癌病人进行术前选择性支气管动脉灌注抗癌药物,2周后手术,获得满意疗效,报道如下。 资料与方法 本组83例,男性72例,女性11例。年龄29～77岁,平均55.7岁。肺癌位于右上叶29例,右中叶4例,右下叶16例,左上叶22例,左下叶12例。中央型66例,占79.5％;周围型17例,占20.5％。鳞癌50例,占60.2％;腺癌21例,占25.3％;小细胞癌3例,占3.6％;粘液表皮样癌2例,占2.6％;巨细胞癌1例,占1.2％;其他6例,占7.2％。
Bronchial arteries are the best way for anticancer drugs to enter lung tumors. In our hospital from February 1989 to December 1994, 83 patients with advanced lung cancer were treated with selective bronchial arterial infusion of anticancer drugs. After 2 weeks of surgery, satisfactory results were obtained. The following are the reports. Materials and Methods 83 patients in this group, 72 males and 11 females. Age 29 to 77 years, average 55.7 years old. Lung cancer was located in 29 cases in the right upper lobe, 4 cases in the right middle lobe, 16 cases in the right lower lobe, 22 cases in the left upper lobe, and 12 cases in the left lower lobe. The central type was 66 cases, accounting for 79.5%; the peripheral type was 17 cases, accounting for 20.5%. 50 cases of squamous cell carcinoma, accounting for 60.2%; 21 cases of adenocarcinoma, accounting for 25.3%; 3 cases of small cell carcinoma, accounting for 3.6%; 2 cases of mucoepidermoid carcinoma, accounting for 2.6%; 1 case of giant cell carcinoma, accounting for 1.2%; 6 cases, accounting for 7.2%.